The Potential of Methocinnamox as a Future Treatment for Opioid Use Disorder: A Narrative Review
The opioid epidemic is an ongoing public health crisis, and the United States health system is overwhelmed with increasing numbers of opioid-related overdoses. Methocinnamox (MCAM) is a novel mu opioid receptor antagonist with an extended duration of action. MCAM has potential to reduce the burden o...
Saved in:
Main Authors: | Colleen G. Jordan (Author), Amy L. Kennalley (Author), Alivia L. Roberts (Author), Kaitlyn M. Nemes (Author), Tenzing Dolma (Author), Brian J. Piper (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Long‐term antagonism and allosteric regulation of mu opioid receptors by the novel ligand, methocinnamox
by: Joshua C. Zamora, et al.
Published: (2021) -
Variation in adverse drug events of opioids in the United States
by: Edward Y. Liu, et al.
Published: (2023) -
Opioid use disorder: current trends and potential treatments
by: Yu Kyung Lee, et al.
Published: (2024) -
Opioids: Addiction, Narrative, Freedom
by: Dolphin-Krute, Maia
Published: (2018) -
Opioids: Addiction, Narrative, Freedom
by: Dolphin-Krute, Maia
Published: (2018)